While the US Supreme Court struck down Myriad Genetics' BRCA1 and BRCA2 gene patents in June, the University of California, San Francisco's Robert Nussbaum writes at Technology Review that monopolies on genetic data are still possible.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.